Trial Profile
Clinical Trials Insight: 700026627
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 31 Aug 2007
Price :
$35
*
At a glance
- Drugs Escherichia coli vaccine (Primary)
- Indications Enterotoxigenic Escherichia coli infections; Traveller's diarrhoea
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Valneva USA
- 31 Aug 2007 New trial record.